70.22.Z - Head office activities and management consultancy
20.42.Z - Manufacture of cosmetics and toilet preparations
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
63.99.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services
70.10.Z - Head office activities
72.11.Z - Scientific research and development activities
73.20.Z - Market research and public opinion polling
82.99.Z - Other business support activities, not elsewhere classified
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,6 | 0,2 | 0,3 | 22,4 |
EBITDA | 1,3 | 0,8 | 1 | 22,7 |
Short time liabilities | 10,9 | 12,7 | 7,6 | -40,1 |
Equity capital | -2,5 | -2,3 | -2,1 | 10,3 |
Operating profit (EBIT) | 1,2 | 0,8 | 1 | 24,9 |
Assets | 127,1 | 124,9 | 125,4 | 0,4 |
Net profit (loss) | 0,6 | 0,2 | 0,2 | 12,7 |
Cash | 0 | 0 | 0 | -67,8 |
Net income from sale | 3,5 | 3,2 | 3,5 | 10,7 |
Liabilities and provisions for liabilities | 129,7 | 127,2 | 127,5 | 0,2 |
Working assets | 3,2 | 0,8 | 1,1 | 40,2 |
Depreciation | 0 | 0 | 0 | -26,5 |
% | % | % | p.p. | |
Profitability of capital | -22,4 | -9,1 | -11,4 | -2,3 |
Equity capital to total assets | -2 | -1,9 | -1,7 | 0,2 |
Gross profit margin | 18 | 6,6 | 7,3 | 0,7 |
EBITDA Margin | 36,6 | 26,2 | 29,1 | 2,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 1139 | 1458 | 789 | -669 |
Current financial liquidity indicator | 0.28757667541503906 | 0.06343702971935272 | 0.1452271044254303 | 0 |
Net dept to EBITDA | 81.4728012084961 | 123.45952606201172 | 101.49169921875 | -22 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane